Tumor samples with activated pathway levels of any of the seven proteins always had a higher fraction of CD8+ T cells, regulatory T cells, and M1 and M2 macrophages in both the exploratory and validation sets (Figs 3E and 4C). The gene discussed is CD8A; the disease is neoplasm.